|Written By:Xinhua News, Posted: Fri, Feb 10, 2012|
Kenya Medical Research Institute (KEMRI)said Tuesday it is doing research on a new tuberculosis (TB) drug that will reduce treatment period for those infected and should be on the market within a year.
KEMRI CEO Dr Solomon Mpoke said that the new drug will reduce treatment period for patients from the current six months down to four months.
“The research on new TB drug is lengthy process but we hope to conclude the study within a year in order to reduce treatment time for TB patients,” Mpoke said.
“The new drug is a partnership of KEMRI, TB Alliance and Britain-based Pharmaceutical company whose main target is to reduce period of treatment,” he said.
Read More: http://kbc.co.ke/news.asp?nid=74904